23
Participants
Start Date
April 17, 2018
Primary Completion Date
January 7, 2021
Study Completion Date
January 21, 2022
Eribulin mesylate
Intravenous infusion
Columbia University Medical Center, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Penn State Health Hershey Medical Center, Hershey
Geisinger Medical Center, Danville
Children's Hospital of Philadelphia, Philadelphia
Nemours / A.I. duPont Hospital for Children, Wilmington
Children's National Medical Center, Washington D.C.
Johns Hopkins University, Baltimore
Children's Hosptial of The King's Daughters, Norfolk
Children's Healthcare of Atlanta, Atlanta
Nemours Children's Clinic, Jacksonville
University of Alabama at Birmingham, Birmingham
Vanderbilt Ingram Cancer Center, Nashville
University of Mississippi Medical Center, Jackson
Norton Children's Hospital, Louisville
Nationwide Children's Hospital, Columbus
Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children - Indiana University, Indianapolis
CS Mott Children's Hospital, Ann Arbor
Blank Children's Hospital, Des Moines
Children's Hospital of Wisconsin, Milwaukee
Children's Hospitals and Clinics of Minnesota, Minneapolis
University of Minnesota, Minneapolis
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Children's Mercy Hospital and Clinics, Kansas City
Children's Medical Center, Dallas
Cook Children's Medical Center, Fort Worth
Methodist Children's Hospital of South Texas, San Antonio
Phoenix Children's Hospital, Phoenix
Children's Hospital Los Angeles, Los Angeles
Southern California Permanente Medical Group, Los Angeles
Rady Children's Hospital- San Diego, San Diego
Loma Linda University Cancer Center, Loma Linda
Children's Hospital of Orange County, Orange
Randall Children's Hospital at Legacy Emanuel, Portland
Seattle Children's, Seattle
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Connecticut Children's Medical Center, Hartford
Hackensack University Medical Center, Hackensack
Rutgers cancer Institute of NJ, New Brunswick
Eisai Inc.
INDUSTRY